Myasthenia Gravis Clinical Trials in Boca Raton, Florida
5 studies are recruiting for myasthenia gravis in Boca Raton, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
The purpose of this study is to assess how well nipocalimab works when compared to efgartigimod in participants with generalized myasthenia gravis (a condition in which body's immune system mistakenly attacks and damages the connection between nerves and muscles causing muscle weakness).
- Stage
- Phase 3
- Ages
- 18 to 74
- Site
- SFM Clinical Research LLC, Boca Raton, Florida
- Locations
- 17 in total
- Run by
- Janssen Research & Development, LLC
-
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
This Phase 2 proof-of-concept, dose range finding study aims to evaluate the safety and efficacy of 3 dose levels of NMD670 vs placebo in adult patients with MG with antibodies against AChR or MuSK, administered twice a day (BID) for 21 days.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- SFM Clinical Research, LLC, Boca Raton, Florida
- Locations
- 40 in total
- Run by
- NMD Pharma A/S
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG). The purpose of the subcutaneous substudy is to evaluate how well it works in the body (pharmacodynamic [PD]) when given as an injection under…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- FM Clinical Research, LLC South Florida Neurology Associates, P. A., Boca Raton, Florida
- Locations
- 112 in total
- Run by
- Janssen Research & Development, LLC
-
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
This is a non-interventional, prospective, post authorization safety study. Patients with gMG who are expected to start treatment with efgartigimod at enrolment or are within their first cycle of efgartigimod at enrolment will be eligible to enroll into the efgartigimod cohort. Patients with gMG wh…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- SFM Clinical Research, LLC, Boca Raton, Florida
- Locations
- 35 in total
- Run by
- argenx
-
A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
The goal of this clinical trial is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of IM-101 in adult participants with AChR antibody-positive gMG. Subsequently, the safety and efficacy of the selected IM-101 dose-regimen will be tested in pa…
- Stage
- Phase 1
- Ages
- 18 to 74
- Site
- SFM Clinical Research, LLC, Boca Raton, Florida
- Locations
- 25 in total
- Run by
- ImmunAbs Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.